Effectiveness, cost-effectiveness and safety of gabapentin versus placebo as an adjunct to multimodal pain regimens in surgical patients: protocol of a placebo controlled randomised controlled trial with blinding (GAP study)

INTRODUCTION: Gabapentin is an antiepileptic drug currently licensed to treat epilepsy and neuropathic pain but has been used off-label to treat acute postoperative pain. The GAP study will compare the effectiveness, cost-effectiveness and safety of gabapentin as an adjunct to standard multimodal an...

Descripción completa

Detalles Bibliográficos
Autores principales: Baos, Sarah, Rogers, Chris A, Abbadi, Reyad, Alzetani, Aiman, Casali, Gianluca, Chauhan, Nilesh, Collett, Laura, Culliford, Lucy, de Jesus, Samantha E, Edwards, Mark, Goddard, Nicholas, Lamb, Jennifer, McKeon, Holly, Molyneux, Mat, Stokes, Elizabeth A, Wordsworth, Sarah, Gibbison, Ben, Pufulete, Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Anaesthesia
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7682449/
https://www.ncbi.nlm.nih.gov/pubmed/33444208
http://dx.doi.org/10.1136/bmjopen-2020-041176

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7682449/
https://www.ncbi.nlm.nih.gov/pubmed/33444208
http://dx.doi.org/10.1136/bmjopen-2020-041176

Ejemplares similares